GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Boundless Bio Inc (NAS:BOLD) » Definitions » Other Stockholders Equity

BOLD (Boundless Bio) Other Stockholders Equity : $-0.00 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Boundless Bio Other Stockholders Equity?

Boundless Bio's Other Stockholders Equity for the quarter that ended in Sep. 2024 was $-0.00 Mil.

Boundless Bio's quarterly Other Stockholders Equity increased from Mar. 2024 ($-0.00 Mil) to Jun. 2024 ($0.00 Mil) but then declined from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($-0.00 Mil).

Boundless Bio's annual Other Stockholders Equity stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).


Boundless Bio Other Stockholders Equity Historical Data

The historical data trend for Boundless Bio's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boundless Bio Other Stockholders Equity Chart

Boundless Bio Annual Data
Trend Dec21 Dec22 Dec23
Other Stockholders Equity
- - -

Boundless Bio Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Boundless Bio Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Boundless Bio Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Boundless Bio's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Boundless Bio Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
9880 Campus Point Drive, Suite 120, San Diego, CA, USA, 92121
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.